| Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease G Marucci, M Buccioni, D Dal Ben, C Lambertucci, R Volpini, F Amenta Neuropharmacology 190, 108352, 2021 | 558 | 2021 |
| 8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands C Lambertucci, I Antonini, M Buccioni, D Dal Ben, DD Kachare, R Volpini, ... Bioorganic & medicinal chemistry 17 (7), 2812-2822, 2009 | 82 | 2009 |
| Outstanding insecticidal activity and sublethal effects of Carlina acaulis root essential oil on the housefly, Musca domestica, with insights on its toxicity on human cells R Pavela, F Maggi, R Petrelli, L Cappellacci, M Buccioni, A Palmieri, ... Food and Chemical Toxicology 136, 111037, 2020 | 78 | 2020 |
| Blue honeysuckle fruit (Lonicera caerulea L.) from eastern Russia: phenolic composition, nutritional value and biological activities of its polar extracts G Caprioli, R Iannarelli, M Innocenti, M Bellumori, D Fiorini, G Sagratini, ... Food & Function 7 (4), 1892-1903, 2016 | 69 | 2016 |
| Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17 M Buccioni, G Marucci, D Dal Ben, D Giacobbe, C Lambertucci, ... Purinergic Signalling 7, 463-468, 2011 | 67 | 2011 |
| Purinergic P2X receptors: structural models and analysis of ligand-target interaction D Dal Ben, M Buccioni, C Lambertucci, G Marucci, A Thomas, R Volpini European journal of medicinal chemistry 89, 561-580, 2015 | 55 | 2015 |
| Evidence for the existence of a specific g protein‐coupled receptor activated by guanosine R Volpini, G Marucci, M Buccioni, D Dal Ben, C Lambertucci, C Lammi, ... ChemMedChem 6 (6), 1074-1080, 2011 | 55 | 2011 |
| Medicinal chemistry of P2X receptors: agonists and orthosteric antagonists C Lambertucci, D Dal Ben, M Buccioni, G Marucci, A Thomas, R Volpini Current medicinal chemistry 22 (7), 915-928, 2015 | 53 | 2015 |
| Synthesis and Biological Evaluation of 2-Alkynyl-N6-methyl-5′-N-methylcarboxamidoadenosine Derivatives as Potent and Highly Selective Agonists for the Human … R Volpini, M Buccioni, D Dal Ben, C Lambertucci, C Lammi, G Marucci, ... Journal of medicinal chemistry 52 (23), 7897-7900, 2009 | 47 | 2009 |
| Synthesis, Biological Evaluation, and Docking Studies of Tetrahydrofuran- Cyclopentanone- and Cyclopentanol-Based Ligands Acting at Adrenergic α1- and Serotonine 5-HT … A Prandi, S Franchini, LI Manasieva, P Fossa, E Cichero, G Marucci, ... Journal of Medicinal Chemistry 55 (1), 23-36, 2012 | 42 | 2012 |
| Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists A Piergentili, W Quaglia, M Giannella, F Del Bello, B Bruni, M Buccioni, ... Bioorganic & Medicinal Chemistry 15 (2), 886-896, 2007 | 39 | 2007 |
| Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications G Marucci, D Dal Ben, M Buccioni, A Martí Navia, A Spinaci, R Volpini, ... Expert Opinion on Therapeutic Patents 29 (12), 943-963, 2019 | 38 | 2019 |
| The 1, 2, 4-triazolo [4, 3-a] pyrazin-3-one as a versatile scaffold for the design of potent adenosine human receptor antagonists. Structural investigations to target the A2A … M Falsini, L Squarcialupi, D Catarzi, F Varano, M Betti, D Dal Ben, ... Journal of Medicinal Chemistry 60 (13), 5772-5790, 2017 | 38 | 2017 |
| Adenosine Receptors as Neuroinflammation Modulators: Role of A1 Agonists and A2A Antagonists A Martí Navia, D Dal Ben, C Lambertucci, A Spinaci, R Volpini, ... Cells 9 (7), 1739, 2020 | 36 | 2020 |
| 1, 2, 4-Benzothiadiazine derivatives as α1 and 5-HT1A receptor ligands A Tait, A Luppi, S Franchini, E Preziosi, C Parenti, M Buccioni, G Marucci, ... Bioorganic & medicinal chemistry letters 15 (4), 1185-1188, 2005 | 36 | 2005 |
| Polar extracts from the berry-like fruits of Hypericum androsaemum L. as a promising ingredient in skin care formulations F Antognoni, M Lianza, F Poli, M Buccioni, C Santinelli, G Caprioli, ... Journal of ethnopharmacology 195, 255-265, 2017 | 31 | 2017 |
| The G protein‐coupled receptor GPR17: overview and update G Marucci, D Dal Ben, C Lambertucci, C Santinelli, A Spinaci, A Thomas, ... ChemMedChem 11 (23), 2567-2574, 2016 | 31 | 2016 |
| Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia A Martire, C Lambertucci, R Pepponi, A Ferrante, N Benati, M Buccioni, ... Journal of Neurochemistry 149 (2), 211-230, 2019 | 30 | 2019 |
| Structure− Activity Relationships in 1, 4-Benzodioxan-Related Compounds. 8.{2-[2-(4-Chlorobenzyloxy) phenoxy] ethyl}-[2-(2, 6-dimethoxyphenoxy) ethyl] amine (Clopenphendioxan … W Quaglia, G Santoni, M Pigini, A Piergentili, F Gentili, M Buccioni, ... Journal of medicinal chemistry 48 (24), 7750-7763, 2005 | 29 | 2005 |
| Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptor D Dal Ben, M Buccioni, C Lambertucci, A Thomas, R Volpini In Silico Pharmacology 1, 1-14, 2013 | 28 | 2013 |
